Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
26.06
+0.50 (1.96%)
At close: May 12, 2025, 4:00 PM
26.69
+0.63 (2.42%)
After-hours: May 12, 2025, 7:09 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.54 billion as of May 12, 2025. Its market cap has decreased by -38.07% in one year.
Market Cap
1.54B
Enterprise Value
550.57M
1-Year Change
-38.07%
Ranking
Category
Stock Price
$26.06
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.54B, an increase of 151.27%. That is a compound annual growth rate of 26.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 1.51B | -51.00% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |